250 related articles for article (PubMed ID: 7621562)
1. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
2. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
Schifter S
Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.
Blind E; Raue F; Klaiber T; Zink A; Schroth J; Buhr H; Ziegler R
J Endocrinol Invest; 1992 Feb; 15(2):93-8. PubMed ID: 1569295
[TBL] [Abstract][Full Text] [Related]
5. A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA.
O'Connell JE; Dominiczak AF; Isles CG; McLellan AR; Davidson G; Gray CE; Connell JM
Clin Endocrinol (Oxf); 1990 Apr; 32(4):417-21. PubMed ID: 1971777
[TBL] [Abstract][Full Text] [Related]
6. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
[TBL] [Abstract][Full Text] [Related]
7. Extent of Surgery for Medullary Thyroid Cancer and Prevalence of Occult Contralateral Foci.
Mao YV; Hughes EG; Steinmetz D; Troob S; Kim J; Tseng CH; Fishbein GA; Sajed DP; Livhits MJ; Yeh MW; Lee D; Angell TE; Wu JX
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):209-214. PubMed ID: 38270925
[TBL] [Abstract][Full Text] [Related]
8. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
Zink A; Blind E; Raue F
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
[TBL] [Abstract][Full Text] [Related]
9. Plasma calcitonin and ACTH responses to lysine vasopressin, calcium and pentagastrin in a patient with medullary thyroid carcinoma associated with Cushing's syndrome.
Shimatsu A; Kato Y; Tanaka I; Nakai Y; Fukunaga M; Imura H
Clin Endocrinol (Oxf); 1983 Feb; 18(2):119-25. PubMed ID: 6133658
[TBL] [Abstract][Full Text] [Related]
10. Thyrotrophin releasing hormone induced calcitonin secretion in patients with medullary carcinoma of the thyroid.
Nakamura H; Someda H; Mori T; Imura H
Clin Endocrinol (Oxf); 1987 Jul; 27(1):69-74. PubMed ID: 3115636
[TBL] [Abstract][Full Text] [Related]
11. Serum thyroglobulin in the diagnosis and management of thyroid carcinoma.
Shlossberg AH; Jacobson JC; Ibbertson HK
Clin Endocrinol (Oxf); 1979 Jan; 10(1):17-27. PubMed ID: 436303
[TBL] [Abstract][Full Text] [Related]
12. (131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.
Lupoli G; Lombardi G; Panza N; Biondi B; Pacilio G; Lastoria S; Salvatore M
Med Oncol Tumor Pharmacother; 1991; 8(1):7-13. PubMed ID: 2041383
[TBL] [Abstract][Full Text] [Related]
13. PDN-21: possible tumor marker for medullary thyroid carcinoma.
Takami H; Shikata J; Horie H; Sekine K; Ito K
J Surg Oncol; 1990 Aug; 44(4):205-7. PubMed ID: 2385096
[TBL] [Abstract][Full Text] [Related]
14. Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatment.
Emmertsen K; Elbrønd O; Nielsen HE; Mosekilde L; Charles P; Kaae S; Hansen HH
Eur J Cancer Clin Oncol; 1982 Jul; 18(7):645-50. PubMed ID: 6127216
[TBL] [Abstract][Full Text] [Related]
15. CT scanning as an adjunct to screening for medullary carcinoma of the thyroid.
Heron CW; Ponder BA; Hunter-Craig ID
Clin Radiol; 1990 Mar; 41(3):209-10. PubMed ID: 1969787
[TBL] [Abstract][Full Text] [Related]
16. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
17. Appropriate and mindful measurement of serum calcitonin in patients with thyroid nodules. A white paper.
Trimboli P; Valderrabano P; Pitoia F; Piccardo A; Bojunga J
Endocrine; 2024 Jan; 83(1):60-64. PubMed ID: 37589814
[TBL] [Abstract][Full Text] [Related]
18. Peroperative studies of S-calcitonin in thyroid and peripheral venous samples from patients with normal C-cells, C-cell hyperplasia, and medullary carcinoma on the thyroid.
Ericsson M; Berg M; Ingemansson S
Res Exp Med (Berl); 1983; 182(2):139-47. PubMed ID: 6867477
[TBL] [Abstract][Full Text] [Related]
19. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
Emmertsen KK; Nielsen HE; Mosekilde L; Hansen HH
Acta Radiol Oncol; 1980; 19(2):85-9. PubMed ID: 6254339
[TBL] [Abstract][Full Text] [Related]
20. Tumor markers and oncogene expression in thyroid cancer using biochemical and immunohistochemical studies.
Hashimoto T; Matsubara F; Mizukami Y; Miyazaki I; Michigishi T; Yanaihara N
Endocrinol Jpn; 1990 Apr; 37(2):247-54. PubMed ID: 1699752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
